Stat talked to patients and their families, many of whom found out the hard way last week when news broke that the anticipated drug was not effective at slowing or preventing neurodegenerative decline. Hopes were high for the trials because there's nothing else in the pipeline. Public health also focuses on grim prison conditions, DNA tests, new depression treatment, diet and asthma, blood cancer research, FDA food safety concerns, brain-healthy diets, gut health, widespread burnout and hearing loss.

from Kaiser Health News https://ift.tt/2TNmYdt

Related Posts:

0 comments:

Post a Comment

Popular Posts